Imprimis launches Surface Pharmaceuticals subsidiary

09:03 EDT 25 Oct 2017 | CentreWatch

Imprimis Pharmaceuticals, an ophthalmology-focused pharmaceutical company, has filed a Form 8-K with the SEC which contains a corporate presentation for its subsidiary, Surface Pharmaceuticals. Surface Pharmaceuticals intends to advance state of the art treatments for ocular surface diseases by seeking FDA approval for three drug candidates for up to five indications. Surface’s drug candidates were formulated using […]

The post Imprimis launches Surface Pharmaceuticals subsidiary appeared first on CenterWatch News Online.

Original Article: Imprimis launches Surface Pharmaceuticals subsidiary


More From BioPortfolio on "Imprimis launches Surface Pharmaceuticals subsidiary"

Quick Search


Relevant Topics

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...